Clinical Study

Daily Optical Coherence Tomography Examinations after First Antivascular Endothelial Growth Factor Injections: An Interventional Case Series

Figure 3

Daily cross-sectional one-line optical coherence tomography (OCT) B-scans over a 30-day period of patient 4. Immediately posttreatment decrease of central retinal thickness with rebound increase of subretinal fluid during follow-up, starting at day 18. On day 30, it is possible to identify the recurrent SRF (yellow arrowhead).